Infection-Linked Cancer Puts Pathology’s First Pass at Risk

Infection-linked cancer is adding biopsy volume while AI targets pathologists’ first review. These systems can flag suspicious regions before a specialist reviews the biopsy, compressing the first pass without replacing diagnosis. The open question is whether this makes pathology faster—or gives hospitals a scapegoat for cutting review time. Is AI taking pathology’s first pass, or are executives hiding behind it? Pick a side in the comments.